 |
|
Pitt, US Army team designs new strategy to find drugs to treat neglected infection
November 03, 2009Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases. The findings are available online today in PLoS Neglected Tropical Diseases.
These drug candidates, which are able to disrupt the growth of a certain stage in the life cycle of the parasite, were found by screening nearly 200,000 chemical compounds and then regrouping them into chemotypes or chemical classes, both new and known, explained senior investigator John S. Lazo, Ph.D., director of Pitt's Drug Discovery Institute and Allegheny Foundation Professor in the Department of Pharmacology and Chemical Biology, Pitt School of Medicine. One of the most potent compounds was further tested in a mouse model of leishmaniasis to confirm it could be effective against the infection.
"We are making real progress in our effort to find new drugs to treat what I'd call the most neglected of the neglected diseases," Dr. Lazo said. "And the method we've developed could be applied to find treatments for other parasitic infections, which are an enormous global health burden."
According to the U.S. Centers for Disease Control and Prevention, each year worldwide, there are about 1.5 million new cases of cutaneous leishmaniasis skin infections, which lead to ulcers, and about 500,000 visceral infections, which lead to fever, weight loss and enlargement of the spleen and liver,. There is no vaccine or drug to prevent the parasitic infection, which is transmitted through sandfly bites.
Interest in developing new treatments for leishmaniasis has grown because of the military presence in Afghanistan and Iraq, where the infection is common, said co-investigator Col. Alan Magill, M.D., director of the Division of Experimental Therapeutics at the Walter Reed Army Institute of Research, Silver Spring, Md.
"Our soldiers are at risk for becoming infected with the Leishmania parasite, but the treatments we have can produce serious side effects," he said. "Also, the organism is becoming resistant to those agents, which haven't changed in 50 years."
For the new study, lead investigator Elizabeth R. Sharlow, Ph.D., a research assistant professor in Pitt School of Medicine's Department of Pharmacology and Chemical Biology, took unconventional approaches to find drug candidates. First, she developed an assay based on the promastigote, the Leishmania life cycle stage that infects the sandfly, to measure the candidate's ability to inhibit the parasite's growth.
"Another unusual step we took was to screen compounds at relatively high concentration, which would make them more likely to affect promastigote growth," Dr. Sharlow said. "The aim was to maximize the diversity of the active compounds, which we then clustered into similar chemotypes with powerful computational methods to make further testing more manageable."
The researchers have dubbed this process "HILCES" for high throughput, low-stringency, computationally enhanced small molecule screening. Low stringency is the drug discovery term for high concentration.
A promising anti-leishmanial compound they found turned out to be disulfiram, or Antabuse, a drug that causes an acute sensitivity to alcohol and that is sometimes prescribed to discourage drinking among patients with chronic alcoholism. Testing in a mouse model of the infection showed that it could slow promastigote growth in a living organism, further demonstrating that the HILCES strategy can reveal effective, as well as unexpected, drug candidates.
"In a million years, we wouldn't have thought about using a compound such as disulfiram for leishmaniasis," noted Dr. Lazo. "It has appeal because it has already been widely used and is inexpensive, but in its current form, it might not be the best option to treat the infection. We plan to develop it further with our colleagues at Walter Reed to improve the compound's potency and efficacy."
All of the primary and confirmation screening data has been made available online, "so it can be data mined by medical researchers and industry anywhere in the world to identify and refine other anti-leishmanial drug candidates," Dr. Lazo added. "And, the same screening techniques could be invaluable to find compounds to treat other parasitic infections."
University of Pittsburgh Schools of the Health Sciences
According to the U.S. Centers for Disease Control and Prevention, each year worldwide, there are about 1.5 million new cases of cutaneous leishmaniasis skin infections, which lead to ulcers, and about 500,000 visceral infections, which lead to fever, weight loss and enlargement of the spleen and liver,. There is no vaccine or drug to prevent the parasitic infection, which is transmitted through sandfly bites.
Interest in developing new treatments for leishmaniasis has grown because of the military presence in Afghanistan and Iraq, where the infection is common, said co-investigator Col. Alan Magill, M.D., director of the Division of Experimental Therapeutics at the Walter Reed Army Institute of Research, Silver Spring, Md.
"Our soldiers are at risk for becoming infected with the Leishmania parasite, but the treatments we have can produce serious side effects," he said. "Also, the organism is becoming resistant to those agents, which haven't changed in 50 years."
For the new study, lead investigator Elizabeth R. Sharlow, Ph.D., a research assistant professor in Pitt School of Medicine's Department of Pharmacology and Chemical Biology, took unconventional approaches to find drug candidates. First, she developed an assay based on the promastigote, the Leishmania life cycle stage that infects the sandfly, to measure the candidate's ability to inhibit the parasite's growth.
"Another unusual step we took was to screen compounds at relatively high concentration, which would make them more likely to affect promastigote growth," Dr. Sharlow said. "The aim was to maximize the diversity of the active compounds, which we then clustered into similar chemotypes with powerful computational methods to make further testing more manageable."
The researchers have dubbed this process "HILCES" for high throughput, low-stringency, computationally enhanced small molecule screening. Low stringency is the drug discovery term for high concentration.
A promising anti-leishmanial compound they found turned out to be disulfiram, or Antabuse, a drug that causes an acute sensitivity to alcohol and that is sometimes prescribed to discourage drinking among patients with chronic alcoholism. Testing in a mouse model of the infection showed that it could slow promastigote growth in a living organism, further demonstrating that the HILCES strategy can reveal effective, as well as unexpected, drug candidates.
"In a million years, we wouldn't have thought about using a compound such as disulfiram for leishmaniasis," noted Dr. Lazo. "It has appeal because it has already been widely used and is inexpensive, but in its current form, it might not be the best option to treat the infection. We plan to develop it further with our colleagues at Walter Reed to improve the compound's potency and efficacy."
All of the primary and confirmation screening data has been made available online, "so it can be data mined by medical researchers and industry anywhere in the world to identify and refine other anti-leishmanial drug candidates," Dr. Lazo added. "And, the same screening techniques could be invaluable to find compounds to treat other parasitic infections."
University of Pittsburgh Schools of the Health Sciences
Infection Current Events and Infection News RSSMany pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission.
On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.
WPI Researchers Take Aim at Hard-to-Treat Fungal Infections
A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections.
An atomic-level look at an HIV accomplice
Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity.
Preventing H1N1 spread to health care workers: Dilemma, debate and confusion
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers.
Sweet -- sugared polymer a new weapon against allergies and asthma
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks.
UAB Researchers Discover Antibody Receptor Identity, Propose Renaming Immune-System Gene
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders.
New culprit for viral infections among elderly -- an overactive immune response
Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people.
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.
Saliva proteins change as women age
In a step toward using human saliva to tell whether those stiff joints, memory lapses, and other telltale signs of aging are normal or red flags for disease, scientists are describing how the protein content of women's saliva change with advancing age.
More Infection Current Events and Infection News Articles
 |
Infection: The Uninvited Universe by Ph.D. Gerald N. Callahan (Author) We use antibacterial soap to wash our hands, we swab doorknobs with antibacterial wipes, we pop antibiotics at the first sign of disease - all to avoid infection. But we are all infected. From before birth to after death, infection is what makes humans human. In a startling, chilling, and inspiring narrative, veteran microbiologist, and author Gerald Callahan, explores the world of the microscopic creatures that live on, in, and around us. Did you know that: our overuse of antibiotics is placing us on then cusp of a resurgence of diseases we had thought long conquered? and, many ailments - from schizophrenia and gastric ulcers to obsessive-compulsive disorder - are now being linked to infections? Infection will awaken you to the microscopic brethren that ensure our health as well as take... |
 |
Infection Starring: Michiko Hada, Mari Hoshino, Tae Kimura, Yoko Maki, Kaho Minami Directed By: Masayuki Ochiai Also With: Hatsuaki Masui (Cinematographer), Masayuki Ochiai (Writer), Yoshifumi Fukazawa (Editor), Kazuya Hamana (Producer), Takashige Ichise (Producer), Yasushi Kotani (Producer), Yuki'e Kitô (Producer), Ryôichi Kimizuka (Writer) From the creators of The Ring, Grudge, and Dark Water comes Infection. A patient in a hospital dies due to malpractice. The doctors responsible panic and stage a cover up. Shortly thereafter, another patient is left at the hospital doors dying of bizarre symptoms. When the patient dies, the doctors involved in the cover up being acting strangely, then one by one, develop the same mysterious and deadly symptoms. |
 |
Infected: A Novel by Scott Sigler (Author) Across America a mysterious disease is turning ordinary people into raving, paranoid murderers who inflict brutal horrors on strangers, themselves, and even their own families. Working under the government’s shroud of secrecy, CIA operative Dew Phillips crisscrosses the country trying in vain to capture a live victim. With only decomposing corpses for clues, CDC epidemiologist Margaret Montoya races to analyze the science behind this deadly contagion. She discovers that these killers all have one thing in common – they’ve been contaminated by a bioengineered parasite, shaped by a complexity far beyond the limits of known science. Meanwhile Perry Dawsey – a hulking former football star now resigned to life as a cubicle-bound desk jockey – awakens one morning to... |
 |
Contagious: A Novel by Scott Sigler (Author) From the acclaimed author of Infected comes an epic and exhilarating story of humanity’s secret battle against a horrific enemy. Across America, a mysterious pathogen transforms ordinary people into raging killers, psychopaths driven by a terrifying, alien agenda. The human race fights back, yet after every battle the disease responds, adapts, using sophisticated strategies and brilliant ruses to fool its pursuers. The only possible explanation: the epidemic is driven not by evolution but by some malevolent intelligence. Standing against this unimaginable threat is a small group, assembled under the strictest secrecy. Their best weapon is hulking former football star Perry Dawsey, left psychologically shattered by his own struggles with this terrible enemy, who possesses... |
 |
Infection by Earwig Enterprises Players roll dice to race around the board, catching diseases and trying to be cured. Catch diseases left in public places, pass diseases to other players, get cured in the medical stations. Medicaid, Christmas bonuses, and the lottery help pay the bills. Diagnose your disease in the Info center, get it wrong and you catch the disease! Disease cards provide a wealth of information, are color coded to indicate severity from basic diseases to major communicable diseases. Each card includes both the common and Latin name, causes, symptoms and treatments. Multiple medical libraries and medical professionals have been consulted to insure the accuracy of the information. Treatment options and prices vary over a large range. Visiting the Voodoo Doctor is the cheapest way to go, but his results... |
 |
Premonition Starring: Hiroshi Mikami, Noriko Sakai, Maki Horikita, Mayumi Ono, Hana Inoue Directed By: Norio Tsuruta Also With: Norio Tsuruta (Writer), Kazuya Hamana (Producer), Satoshi Fukushima (Producer), Takashige Ichise (Producer), Yasushi Kotani (Producer), Jirô Tsunoda (Writer), Noboru Takagi (Writer) They are used to tell the past, but for a few unlucky individuals, they foretell the future. When Hideki picks up a newspaper he knows what he will see...death. Foretelling ill-omened fate of everything from slayings to train crashes, there is nothing Hideki can do to stop the event... or is there? When the paper predicts the demise of his daughter in a car crash, Hideki seeks out other like himself, searching for a way to change the future. |
 |
Zombies: A Record of the Year of Infection by Don Roff (Author), Chris Lane (Author) The year is 2011, and what starts as a pervasive and inexplicable illness ends up as a zombie infestation that devastates the world's population. Taking the form of a biologist's illustrated journal found in the aftermath of the attack, this pulse-pounding, suspenseful tale of zombie apocalypse follows the narrator as he flees from city to countryside and heads north to Canada, where he hopes the undead will be slowed by the colder climate. Encountering scattered humans and scores of the infected along the way, he fills his notebook with graphic drawings of the zombies and careful observations of their behavior, along with terrifying tales of survival. This frightening new contribution to the massively popular zombie resurgence will keep fans on the edge of their seats right up to the... |
 |
Zombies: A Record of the Year of Infection by Simon & Schuster UK (Publisher) |
 |
The Bible Cure for Candida and Yeast Infections (Bible Cure Series) by Don Colbert (Author) People who suffer from fatigue, muscle aches, food sensitivities, psoriasis, asthma and many other common complaints may actually have a yeast infection. Too much yeast (specifically, "Candida Albicans") in the body is a problem that applies equally to both men and women. Candida Albican, a common yeast, normally lives in the human body where it causes no problems-provided the body's biochemistry is balanced and the immune system is strong. Dr. Don Colbert shares his insight on yeast infections and suggests cures to prevent them from weakening the immune system. |
 |
Treat Ear and Respiratory Infections Without Antibiotics Starring: Dr. Mary Ann Block Directed By: Joan Anderson In this unique video, Dr. Mary Ann Block demonstrates gentle techniques based on the century-old philosophy of osteopathic medicine which she taught in medical school. This technique helps to drain ears and upper respiratory tract and boost the immune system without antibiotics. Dr. Block explains, in easy to understand terms, what you can do at home to treat and help prevent future infections. In this video you will learn: the underlying causes of chronic ear and respiratory infections, effective treatments you can do at home, powerful techniques Dr. Block taught to students in medical school, how to help prevent recurring infections, ways to help stay healthy and support the immune system, and how to stop the vicious cycle of: infections, antibiotics, immune system suppression, more... |
| © 2009 BrightSurf.com |